Ponta, Simone
Bonato, Angela
Neidenbach, Philipp
Bruhin, Valentino F.
Laurent, Alexis
Applegate, Lee Ann
Zenobi-Wong, Marcy
Barreto, Goncalo
Funding for this research was provided by:
Suomen Kulttuurirahasto (00220103)
University of Helsinki
Article History
Received: 5 January 2024
Accepted: 26 February 2024
First Online: 11 March 2024
Declarations
:
: Ethics approval for the use of human polydactyly chondrocytes, FE002 chondroprogenitor cells and osteoarthritis chondrocytes are described in detail in the Material and Methods section.
: Not applicable.
: The authors declare no competing interests.